Terumo's Cross-Seal Suture-Mediated Vascular Closure Device

November 4, 2022—The objective of the prospective, multicenter, single-arm Cross-Seal investigational device exemption (IDE) trial was to determ

Related Keywords

Nevada , United States , Prakash Krishnan , Las Vegas , Foundation On , Terumo Interventional Systems , Late Breaking Clinical Trials , Viva22 , Bct , Across Seal , Dude , Investigational Device Exemption , Cd , Hemostasis , Tavr , Bulevar , Var , Balloon Aortic Valvuloplasty , Ith ,